* USANA Health Sciences Inc USNA.N USNA.K is expected
to show
a fall in quarterly revenue when it reports results on April
25.
* The Salt Lake City Utah-based company is expected to
report a
12.0% decrease in revenue to $240.224 million from $272.87
million a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for USANA Health
Sciences Inc
is for earnings of 77 cents per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for USANA
Health
Sciences Inc is $52.5, below its last closing price of $65.10.
This summary was machine generated April 21 at 21:58 GMT. All
figures in US dollars unless otherwise stated